E-LIB Suche - Ergebnisse für: Vieito, María

1

Enhancing Tumor Microstructural Quantification With Machine..:

Macarro, Carlos ; Bernatowicz, Kinga ; Garcia‐Ruiz, Alonso...
Journal of Magnetic Resonance Imaging. , 2024

Link: https://doi.org/10.1002/..

2

Safety and clinical activity of JNJ-78306358, a human leuko..:

Geva, Ravit ; Vieito, Maria ; Ramon, Jorge...
Cancer Immunology, Immunotherapy. 73 (2024) 10 - p. , 2024

Link: https://doi.org/10.1007/..

3

147 Evolution of phase 1 clinical trials for head and neck ..:

Rojas, Katerin ; Hernando, Alberto ; Assaf, Juan...
Radiotherapy and Oncology. 192 (2024) - p. S171-S172 , 2024

Link: https://doi.org/10.1016/..

4

Safety, pharmacokinetics, pharmacodynamics, and antitumor a..:

Baranda, Joaquina C. ; Robbrecht, Debbie ; Sullivan, Ryan...
Clinical and Translational Science. 17 (2024) 6 - p. , 2024

Link: https://doi.org/10.1111/..

5

Agnostic drug development revisited:

Hernando-Calvo, Alberto ; Rossi, Alice ; Vieito, Maria..
Cancer Treatment Reviews. 128 (2024) - p. 102747 , 2024

Link: https://doi.org/10.1016/..

6

The role of vaccines in glioblastoma—Updated clinical resul..:

, In: New Insights Into Glioblastoma,

Vieito, Maria ; Casalino, Simona ; Moreno, Montse. - p. 505-513 , 2023

Link: https://doi.org/10.1016/..

7

Selective HIF2A Inhibitors in the Management of Clear Cell ..:

Suárez, Cristina ; Vieito, Maria ; Valdivia, Augusto..
Medical Sciences. 11 (2023) 3 - p. 46 , 2023

Link: https://doi.org/10.3390/..

8

Pemigatinib For Previously Treated Central Nervous System T..:

Spanggaard, Iben ; Matrana, Marc ; Rocha-Lima, Caio...
Neurology. 100 (2023) 17_supplement_2 - p. , 2023

Link: https://doi.org/10.1212/..

9

BET inhibitor trotabresib in heavily pretreated patients wi..:

Moreno, Victor ; Vieito, Maria ; Sepulveda, Juan Manuel...
Nature Communications. 14 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

10

Tusamitamab Ravtansine in Patients with Advanced Solid Tumo..:

Tabernero, Josep ; Bedard, Philippe L. ; Bang, Yung-Jue...
Cancer Research Communications. 3 (2023) 8 - p. 1662-1671 , 2023

Link: https://doi.org/10.1158/..

11

CTIM-25. EO2401 PEPTIDE IMMUNOTHERAPY + NIVOLUMAB +/- BEVAC..:

Reardon, David ; Idbaih, Ahmed ; Vieito, Maria...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v67-v68 , 2023

Link: https://doi.org/10.1093/..

12

Nutritional status associates with immunotherapy clinical o..:

Hernando-Calvo, Alberto ; Mirallas, Oriol ; Marmolejo, David...
Oral Oncology. 140 (2023) - p. 106364 , 2023

Link: https://doi.org/10.1016/..

13

A pan-cancer clinical platform to predict immunotherapy out..:

Hernando-Calvo, Alberto ; Vila-Casadesús, Maria ; Bareche, Yacine...
Med. 4 (2023) 10 - p. 710-727.e5 , 2023

Link: https://doi.org/10.1016/..

14

RTID-03. A PHASE 1/2 STUDY OF THE WEE1 INHIBITOR DEBIO 0123..:

Roth, Patrick ; Papadopoulos, Kyriakos P ; Vieito, Maria...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v258-v259 , 2023

Link: https://doi.org/10.1093/..

15

Contributors:

, In: New Insights Into Glioblastoma,

Aghajani, Samira ; Ahmadi, Mazaher ; Akimitsu, Nobuyoshi... - p. xix-xxv , 2023

Link: https://doi.org/10.1016/..